NovaBay Pharmaceuticals (NYSE:NBY) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a research note issued to investors on Thursday. The brokerage issued a hold rating on the stock. Separately, Ascendiant Capital Markets reduced their price target on NovaBay Pharmaceuticals from $8.00 to $0.85 and set a “buy” rating on the stock in a […]
StockNews.com initiated coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a research note issued to investors on Thursday. The brokerage issued a hold rating on the stock. Separately, Ascendiant Capital Markets reduced their price target on NovaBay Pharmaceuticals from $8.00 to $0.85 and set a “buy” rating on the stock in a […]
